Comparison Between the Short-Term Outcomes of Bevacizumab and Ziv-Aflibercept in the Treatment of Primary Diabetic Macular Oedema

Acta Ophthalmologica - United States
doi 10.1111/aos.13352
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

One-Year Treatment Outcomes of Ziv-Aflibercept for Treatment-Naïve Macular Oedema in Branch Retinal Vein Occlusion

Acta Ophthalmologica
MedicineOphthalmology
2017English

Aflibercept – Setting Its Sights on Diabetic Macular Oedema

European Ophthalmic Review
2014English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

Treatment Outcomes of Ziv-Aflibercept for Treatment-Naïve Polypoidal Choroidal Vasculopathy

Acta Ophthalmologica
MedicineOphthalmology
2017English

Short Term Effect of Intravitreal Bevacizumab for Diabetic Macular Edema Associated With Epiretinal Membrane

Romanian journal of ophthalmology
Medicine
2018English

Intravitreal Bevacizumab for the Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Diabetic Macular Oedema: Under-Represented in the Genetic Analysis of Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Diabetic Macular Oedema and the Importance of Vascular Endothelial Growth Factor Therapies in Its Treatment

European Ophthalmic Review
2014English

Systematic Review and Mixed Treatment Comparison of Intravitreal Aflibercept With Other Therapies for Diabetic Macular Edema (DME)

BMC Ophthalmology
MedicineOphthalmology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy